E
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -283.00K -377.10K -207.70K -349.80K -568.10K
Total Depreciation and Amortization 259.50K 252.90K 247.70K 179.60K 258.70K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 345.30K 567.10K 340.40K -190.40K 318.30K
Change in Net Operating Assets -385.70K -521.10K -1.80M -348.30K -1.82M
Cash from Operations -63.80K -78.20K -1.42M -708.90K -1.81M
Capital Expenditure -876.90K -678.90K -402.80K 627.80K -138.70K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -22.00K -1.54M -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -122.40K -148.40K -108.30K -145.10K -18.60K
Cash from Investing -1.02M -2.37M -511.00K 482.70K -157.30K
Total Debt Issued 1.76M 438.00K 1.26M 81.20K 2.94M
Total Debt Repaid -957.00K -1.17M -440.00K 926.60K -165.00K
Issuance of Common Stock 960.00K 5.29M 1.99M -- --
Repurchase of Common Stock -- -- -- -100.00 --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -403.00K -889.00K -245.00K -663.30K -680.00K
Cash from Financing 993.50K 2.68M 1.90M 253.20K 1.56M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -91.60K 235.30K -30.40K 26.90K -406.30K
Weiss Ratings